Hepatitis C Articles (HCV)
Back
 
GT4 Abbvie/ GS5816+Sofosbuvir
GT4:
All-Oral Therapy With Daclatasvir in Combination With Asunaprevir and BMS-791325 for Treatment-Naive Patients With Chronic HCV Genotype 4 Infection
- (05/06/14)
RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/r + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION
- (04/16/14)
Sofosbuvir Plus Ribavirin, an Interferon-Free Regimen, in the Treatment of Treatment-Naïve and -Experienced Patients With Chronic Genotype 4 HCV Infection
- (04/16/14)
Safety and Efficacy of Treatment With Interferon-Free, Ribavirin-Free Combination of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naïve Patients With Genotypes 1-6 HCV Infection
- (04/14/14)
View Older Articles
Back to Top
www.natap.org